|
|
Initial Phase I/II trastuzumab trials
|
|
Pivotal Phase III trastuzumab trial
|
|
Preclinical data on trastuzumab/chemotherapy
combinations
|
|
Phase II trials of trastuzumab/chemotherapy
combinations
|
|
Cardiotoxicity with different chemotherapy combinations |
|
Carboplatin or cisplatin plus docetaxel/trastuzumab
(CTH) |
|
Preclinical data on trastuzumab/hormonal therapy
combinations |
|
Duration of trastuzumab therapy |
|
Use of trastuzumab for metastatic disease |
|
Adjuvant trastuzumab trials |
|
Neoadjuvant trastuzumab trials |
|
Assessing HER2 status |
|
|
|
A chronology of select
breast cancer publications by Dr Slamon |
|
|
San Antonio
Breast Cancer Symposium
Clinical Trials Exhibit.
|
|
|
|